The TCF team is excited to be in Chicago for the American Society of Clinical Oncology 2025 Annual Meeting. In addition to attending meetings and sessions alongside 40,000 attendees, comprised of oncologists, researchers, healthcare professionals, patient advocates, and industry partners, TCF is proud to be hosting a Patient Advocacy booth for the first time. Throughout the event, we will be sharing information with this global audience about our work driving #rarecancer research, convening experts, and empowering community. We look forward to sharing more photos and an overview of the weekend soon! #patientadvocacy #chicago #rarecancers #ASCO25 (fb)

Kristen Palma, President of TargetCancer Foundation, has written a moving reflection on the significance of last week’s major #cholangiocarcinoma research announcement. Kristen revisits how TCF’s partnership with Dr Nabeel Bardeesy began in 2010, and discusses the personal impact of the success achieved by the recent launch of the Cholangiocarcinoma Cell Line Atlas by The Bardeesy Lab. We encourage you to read the full story on our blog: https://targetcancer.org/ontarget/news/translating-loss-into-discovery-pauls-legacy/ If you missed the initial publication of Kristen’s piece in this week’s special issue of On Target, our monthly newsletter, sign up now to receive future issues by visiting: https://targetcancer.org/contact/ #biliarytractcancer #scientificresearch #legacy (fb)